Abstract

Genome-wide association studies identified the BIN1 locus as a leading modulator of genetic risk in Alzheimer's disease (AD). One limitation in understanding BIN1's contribution to AD is its unknown function in the brain. AD-associated BIN1 variants are generally noncoding and likely change expression. Here, we determined the effects of increasing expression of the major neuronal isoform of human BIN1 in cultured rat hippocampal neurons. Higher BIN1 induced network hyperexcitability on multielectrode arrays, increased frequency of synaptic transmission, and elevated calcium transients, indicating that increasing BIN1 drives greater neuronal activity. In exploring the mechanism of these effects on neuronal physiology, we found that BIN1 interacted with L-type voltage-gated calcium channels (LVGCCs) and that BIN1–LVGCC interactions were modulated by Tau in rat hippocampal neurons and mouse brain. Finally, Tau reduction prevented BIN1-induced network hyperexcitability. These data shed light on BIN1's neuronal function and suggest that it may contribute to Tau-dependent hyperexcitability in AD.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 6: high throughput raw electrophysiologic recordings of neuronal activity using Axion Biosciences Maesto are deposited at: https://uab.box.com/s/rdjp74ba7stgb2dfrxgbyj507b94tjhn.Brief Analysis used is described in the methods section, in-depth analysis description is publicly available at: https://www.axionbiosystems.com/products/axis-software.

Article and author information

Author details

  1. Yuliya Voskobiynyk

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  2. Jonathan R Roth

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8978-4507
  3. J Nicholas Cochran

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  4. Travis Rush

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  5. Nancy VN Carullo

    Neurology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9197-5046
  6. Jacob S Mesina

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  7. Mohammad Waqas

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  8. Rachael M Vollmer

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
  9. Jeremy J Day

    Department of Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7361-3399
  10. Lori L McMahon

    Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1104-6584
  11. Erik D Roberson

    Neurology, Neurobiology, University of Alabama at Birmingham, Birmingham, United States
    For correspondence
    eroberson@uabmc.edu
    Competing interests
    Erik D Roberson, EDR is an owner of intellectual property relating to Tau.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1810-9763

Funding

National Institutes of Health (RF1AG059405)

  • Erik D Roberson

National Institutes of Health (R01NS075487)

  • Erik D Roberson

National Institutes of Health (R01MH114990)

  • Jeremy J Day

National Institutes of Health (T32NS095775)

  • Yuliya Voskobiynyk

National Institutes of Health (T32NS061788)

  • Jonathan R Roth

Alzheimer's Association

  • Erik D Roberson

Weston Brain Institute

  • Jonathan R Roth
  • Travis Rush
  • Erik D Roberson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#20450) of the University of Alabama at Birmingham. The protocol was approved by the Committee on the Ethics of Animal Experiments of the University of Alabama at Birmingham.

Copyright

© 2020, Voskobiynyk et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,374
    views
  • 599
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yuliya Voskobiynyk
  2. Jonathan R Roth
  3. J Nicholas Cochran
  4. Travis Rush
  5. Nancy VN Carullo
  6. Jacob S Mesina
  7. Mohammad Waqas
  8. Rachael M Vollmer
  9. Jeremy J Day
  10. Lori L McMahon
  11. Erik D Roberson
(2020)
Alzheimer's disease risk gene BIN1 induces Tau-dependent network hyperexcitability
eLife 9:e57354.
https://doi.org/10.7554/eLife.57354

Share this article

https://doi.org/10.7554/eLife.57354

Further reading

    1. Neuroscience
    Charles R Heller, Gregory R Hamersky, Stephen V David
    Research Article

    Categorical sensory representations are critical for many behaviors, including speech perception. In the auditory system, categorical information is thought to arise hierarchically, becoming increasingly prominent in higher-order cortical regions. The neural mechanisms that support this robust and flexible computation remain poorly understood. Here, we studied sound representations in the ferret primary and non-primary auditory cortex while animals engaged in a challenging sound discrimination task. Population-level decoding of simultaneously recorded single neurons revealed that task engagement caused categorical sound representations to emerge in non-primary auditory cortex. In primary auditory cortex, task engagement caused a general enhancement of sound decoding that was not specific to task-relevant categories. These findings are consistent with mixed selectivity models of neural disentanglement, in which early sensory regions build an overcomplete representation of the world and allow neurons in downstream brain regions to flexibly and selectively read out behaviorally relevant, categorical information.

    1. Neuroscience
    2. Stem Cells and Regenerative Medicine
    Amber R Philp, Carolina R Reyes ... Francisco J Rivera
    Short Report

    Revealing unknown cues that regulate oligodendrocyte progenitor cell (OPC) function in remyelination is important to optimise the development of regenerative therapies for multiple sclerosis (MS). Platelets are present in chronic non-remyelinated lesions of MS and an increase in circulating platelets has been described in experimental autoimmune encephalomyelitis (EAE) mice, an animal model for MS. However, the contribution of platelets to remyelination remains unexplored. Here we show platelet aggregation in proximity to OPCs in areas of experimental demyelination. Partial depletion of circulating platelets impaired OPC differentiation and remyelination, without altering blood-brain barrier stability and neuroinflammation. Transient exposure to platelets enhanced OPC differentiation in vitro, whereas sustained exposure suppressed this effect. In a mouse model of thrombocytosis (Calr+/-), there was a sustained increase in platelet aggregation together with a reduction of newly-generated oligodendrocytes following toxin-induced demyelination. These findings reveal a complex bimodal contribution of platelet to remyelination and provide insights into remyelination failure in MS.